PRESS RELEASE published on 06/28/2024 at 09:00, 1 year 11 months ago Q1 2024 Financial Results CannaPharmaRx reports Q1 2024 financial results with revenue commencing. The company anticipates accelerated growth, international expansion, and strategic partnerships Financial Results Revenue Growth Q1 2024 CannapharmaRx
BRIEF published on 05/20/2024 at 19:50, 2 years 1 month ago CannaPharmaRx organisera une conférence téléphonique pour les investisseurs le 21 mai 2024 Mise À Jour Financière Conférence Téléphonique Pour Les Investisseurs Production De Cannabis Doyen Medwid
BRIEF published on 05/20/2024 at 19:50, 2 years 1 month ago CannaPharmaRx to Host Investor Conference Call on May 21, 2024 Investor Conference Call Financial Update Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 19:45, 2 years 1 month ago CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. (OTC PINK:CPMD) will host an investor conference call on May 21, 2024, at 1PM Eastern time to provide updates on financials, products, distribution, and expansion Investor Conference Call Financial Update CannapharmaRx Cannabis Production CPMD
BRIEF published on 05/20/2024 at 18:35, 2 years 1 month ago CannaPharmaRx organisera une conférence téléphonique avec les investisseurs Mise À Jour Financière Conférence Des Investisseurs CannapharmaRx Production De Cannabis Doyen Medwid
BRIEF published on 05/20/2024 at 18:35, 2 years 1 month ago CannaPharmaRx to Host Investor Conference Call Investor Conference Financial Update CannapharmaRx Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 18:30, 2 years 1 month ago CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. to hold investor conference call on May 21, 2024, providing updates on financials, products, orders, and forecasts. Visit www.cannapharmarx.com for details Investor Conference Call Financial Update CannapharmaRx Cannabis Production Forecasted Revenues
BRIEF published on 04/02/2024 at 12:05, 2 years 2 months ago CannapharmaRx rembourse avec succès les billets convertibles pour renforcer sa position Remboursement De Dette Billets Convertibles CannapharmaRx Production De Cannabis Intérêts Des Actionnaires
BRIEF published on 04/02/2024 at 12:05, 2 years 2 months ago CannapharmaRx Successfully Repays Convertible Notes to Strengthen Position Convertible Notes Debt Repayment Shareholder Interests CannapharmaRx Cannabis Production
PRESS RELEASE published on 04/02/2024 at 12:00, 2 years 2 months ago CannapharmaRx Pays Off Convertible Notes CannapharmaRx, Inc. announces the extinguishment of convertible notes to avoid stock dilution and strengthen the company. CEO Dean Medwid discusses the positive impact on future growth and valuation Convertible Notes Future Growth CannapharmaRx Stock Dilution CEO Dean Medwid
Published on 06/26/2026 at 01:40, 6 hours 29 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 8 hours 39 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 9 hours 39 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 10 hours 37 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 16 hours 39 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 07:30, 39 minutes ago REINET INVESTMENTS S.C.A. ANNOUNCES REVISED DATE FOR ANNUAL GENERAL MEETING
Published on 06/26/2026 at 07:30, 39 minutes ago THE NAGA GROUP AG CONFIRMS FY 2025 REVENUES AND REPORTS STRONGER-THAN-EXPECTED EBITDA
Published on 06/26/2026 at 07:30, 39 minutes ago Pyrum Innovations AG reports results for the first three months of 2026
Published on 06/26/2026 at 04:20, 3 hours 49 minutes ago VARON Helps Travelers Breathe Easy This Summer With Portable Oxygen Concentrators Built for Mobility
Published on 06/26/2026 at 02:05, 6 hours 4 minutes ago VARON Marks "Love Your Lungs Week" With a Call to Prioritize Summer Respiratory Health Across Europe
Published on 06/26/2026 at 07:00, 1 hour 9 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 1 hour 9 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 13 hours 24 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 13 hours 39 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 14 hours 19 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
